138 related articles for article (PubMed ID: 12605033)
21. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Nielsen TO; Hsu FD; Jensen K; Cheang M; Karaca G; Hu Z; Hernandez-Boussard T; Livasy C; Cowan D; Dressler L; Akslen LA; Ragaz J; Gown AM; Gilks CB; van de Rijn M; Perou CM
Clin Cancer Res; 2004 Aug; 10(16):5367-74. PubMed ID: 15328174
[TBL] [Abstract][Full Text] [Related]
22. A methodological study of genome-wide DNA methylation analyses using matched archival formalin-fixed paraffin embedded and fresh frozen breast tumors.
Espinal AC; Wang D; Yan L; Liu S; Tang L; Hu Q; Morrison CD; Ambrosone CB; Higgins MJ; Sucheston-Campbell LE
Oncotarget; 2017 Feb; 8(9):14821-14829. PubMed ID: 28118602
[TBL] [Abstract][Full Text] [Related]
23. Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.
Gonçalves A; Charafe-Jauffret E; Bertucci F; Audebert S; Toiron Y; Esterni B; Monville F; Tarpin C; Jacquemier J; Houvenaeghel G; Chabannon C; Extra JM; Viens P; Borg JP; Birnbaum D
Mol Cell Proteomics; 2008 Aug; 7(8):1420-33. PubMed ID: 18426791
[TBL] [Abstract][Full Text] [Related]
24. p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas.
Matos I; Dufloth R; Alvarenga M; Zeferino LC; Schmitt F
Virchows Arch; 2005 Oct; 447(4):688-94. PubMed ID: 16012853
[TBL] [Abstract][Full Text] [Related]
25. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.
Amatschek S; Koenig U; Auer H; Steinlein P; Pacher M; Gruenfelder A; Dekan G; Vogl S; Kubista E; Heider KH; Stratowa C; Schreiber M; Sommergruber W
Cancer Res; 2004 Feb; 64(3):844-56. PubMed ID: 14871811
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.
Kreike B; van Kouwenhove M; Horlings H; Weigelt B; Peterse H; Bartelink H; van de Vijver MJ
Breast Cancer Res; 2007; 9(5):R65. PubMed ID: 17910759
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.
Sotiriou C; Wirapati P; Loi S; Harris A; Fox S; Smeds J; Nordgren H; Farmer P; Praz V; Haibe-Kains B; Desmedt C; Larsimont D; Cardoso F; Peterse H; Nuyten D; Buyse M; Van de Vijver MJ; Bergh J; Piccart M; Delorenzi M
J Natl Cancer Inst; 2006 Feb; 98(4):262-72. PubMed ID: 16478745
[TBL] [Abstract][Full Text] [Related]
28. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
Colombo PE; Milanezi F; Weigelt B; Reis-Filho JS
Breast Cancer Res; 2011 Jun; 13(3):212. PubMed ID: 21787441
[TBL] [Abstract][Full Text] [Related]
29. Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues.
Mullins M; Perreard L; Quackenbush JF; Gauthier N; Bayer S; Ellis M; Parker J; Perou CM; Szabo A; Bernard PS
Clin Chem; 2007 Jul; 53(7):1273-9. PubMed ID: 17525107
[TBL] [Abstract][Full Text] [Related]
30. Classification of breast carcinomas according to gene expression profiles.
Moldovan L; Mitroi A; Petrescu CM; Aschie M
J Med Life; 2013 Mar; 6(1):14-7. PubMed ID: 23599813
[TBL] [Abstract][Full Text] [Related]
31. Application of a novel and low cost technique to construct paraffin tissue microarrays out of paraffinised needle biopsy specimens from patients with breast cancer.
Vogel UF; Bültmann B
J Clin Pathol; 2010 Jul; 63(7):640-3. PubMed ID: 20591915
[TBL] [Abstract][Full Text] [Related]
32. Gene discovery in bladder cancer progression using cDNA microarrays.
Sanchez-Carbayo M; Socci ND; Lozano JJ; Li W; Charytonowicz E; Belbin TJ; Prystowsky MB; Ortiz AR; Childs G; Cordon-Cardo C
Am J Pathol; 2003 Aug; 163(2):505-16. PubMed ID: 12875971
[TBL] [Abstract][Full Text] [Related]
33. Use of formalin-fixed paraffin-embedded samples for gene expression studies in breast cancer patients.
Musella V; Callari M; Di Buduo E; Scuro M; Dugo M; Miodini P; Bianchini G; Paolini B; Gianni L; Daidone MG; Cappelletti V
PLoS One; 2015; 10(4):e0123194. PubMed ID: 25844937
[TBL] [Abstract][Full Text] [Related]
34. Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.
Bane AL; Pinnaduwage D; Colby S; Reedijk M; Egan SE; Bull SB; O'Malley FP; Andrulis IL
Breast Cancer Res Treat; 2009 Sep; 117(1):183-91. PubMed ID: 18563556
[TBL] [Abstract][Full Text] [Related]
35. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
Sørlie T; Perou CM; Tibshirani R; Aas T; Geisler S; Johnsen H; Hastie T; Eisen MB; van de Rijn M; Jeffrey SS; Thorsen T; Quist H; Matese JC; Brown PO; Botstein D; Lønning PE; Børresen-Dale AL
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10869-74. PubMed ID: 11553815
[TBL] [Abstract][Full Text] [Related]
36. Gene expression variation between distinct areas of breast cancer measured from paraffin-embedded tissue cores.
Schobesberger M; Baltzer A; Oberli A; Kappeler A; Gugger M; Burger H; Jaggi R
BMC Cancer; 2008 Nov; 8():343. PubMed ID: 19032762
[TBL] [Abstract][Full Text] [Related]
37. Predicting features of breast cancer with gene expression patterns.
Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
[TBL] [Abstract][Full Text] [Related]
38. The phenotypic spectrum of basal-like breast cancers: a critical appraisal.
Fadare O; Tavassoli FA
Adv Anat Pathol; 2007 Sep; 14(5):358-73. PubMed ID: 17717437
[TBL] [Abstract][Full Text] [Related]
39. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.
Tebbit CL; Zhai J; Untch BR; Ellis MJ; Dressman HK; Bentley RC; Baker JA; Marcom PK; Nevins JR; Marks JR; Olson JA
Breast Cancer Res Treat; 2009 Dec; 118(3):635-43. PubMed ID: 19224362
[TBL] [Abstract][Full Text] [Related]
40. Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker.
Liu JJ; Shen R; Chen L; Ye Y; He G; Hua K; Jarjoura D; Nakano T; Ramesh GK; Shapiro CL; Barsky SH; Gao JX
Int J Clin Exp Pathol; 2010 Mar; 3(4):328-37. PubMed ID: 20490325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
